CAS 88599-32-0

ethyl 2-(carbamoyloxy)benzoate

Description:

Ethyl 2-(carbamoyloxy)benzoate, with the CAS number 88599-32-0, is an organic compound that belongs to the class of esters. It features a benzoate structure where an ethyl group is esterified to a carbamoyloxy group at the ortho position of the benzene ring. This compound is characterized by its functional groups, including the ester and carbamoyloxy moieties, which contribute to its chemical reactivity and potential applications. Ethyl 2-(carbamoyloxy)benzoate is typically a colorless to pale yellow liquid or solid, depending on its purity and form. It is soluble in organic solvents and may exhibit moderate solubility in water. The compound may be used in various applications, including pharmaceuticals, agrochemicals, and as an intermediate in organic synthesis. Its properties, such as melting point, boiling point, and specific reactivity, can vary based on the conditions and purity of the sample. Safety data should be consulted for handling and storage, as with any chemical substance.

Formula: C₁₀H₁₁NO₄

InChI: InChI=1/C10H11NO4/c1-2-14-9(12)7-5-3-4-6-8(7)15-10(11)13/h3-6H,2H2,1H3,(H2,11,13)

SMILES: CCOC(=O)c1ccccc1OC(=N)O

Ethyl 2-carbamoyloxybenzoate

CAS: 88599-32-0

Ethyl 2-carbamoyloxybenzoate

Purity: ≥95%

Molecular weight: 209.2g/mol

Ref: 54-BUP10016

Ethyl 2-carbamoyloxybenzoate

CAS: 88599-32-0

ECXB, a synthetic derivative of benzoyloxybenzoic acid, is used in drug synthesis and biochemical studies.

Formula: C₁₀H₁₁NO₄

Purity: 99.47%

Color and Shape: Solid

Molecular weight: 209.2

Ref: TM-T50036

Ethyl 2-(carbamoyloxy)benzoate

CAS: 88599-32-0

Ethyl 2-(carbamoyloxy)benzoate (EMCB) is a prodrug that is hydrolyzed in vivo to the active form, fenoprofen. It has been shown to inhibit prostaglandin synthesis and to have analgesic, antipyretic, and anti-inflammatory properties. EMBC inhibits the enzyme cyclooxygenase which converts arachidonic acid into prostaglandins. In humans, EMBC is absorbed from the gastrointestinal tract and excreted in the urine unchanged or as metabolites. The drug has been found to be effective against activated platelets and plasma albumin, but not against intestinal enzymes such as ileal or pancreatic amylases. EMBC also has contraceptive properties and can be used as an oral contraceptive for up to three months at a time. EMBC may interact with other drugs that are broken down by cytochrome P450 enzymes, including acetylsalicylic acid and corticoster

Formula: C₁₀H₁₁NO₄

Purity: Min. 95%

Molecular weight: 209.2 g/mol

Ref: 3D-NDA59932